The Abu Dhabi Stem Cell Center announced the installation of an advanced medical device that would help scientists enhance capabilities, capabilities and research and achieve the best results for treating patients with the "Covid 19" virus.
The center has introduced a "Helios" device to measure the flow of cells, a device capable of counting and classifying cells of any sample. The cost of this unique device in the Middle East is 3.6 million dirhams, which is a major investment by the center in developing its efficiency and pioneering experiences to overcome the virus.
Thanks to this device, scientists at the center will be able to quickly and accurately identify individual human cells, which will allow them to study and monitor the patient's immune response to the virus, and to uncover new horizons about the epidemic based on the patient's defense ability.
A spokesman for the Abu Dhabi Stem Cell Center said: "This device will enable us to study clinical results and changes when infections occur or any change in immune functions through blood samples of patients / Covid-19 / and this will allow us to address some urgent questions that remain unanswered. Regarding this epidemic. "
Scientists are searching for immune features and molecular mechanisms that increase the severity of HIV / Covid-19 / infection, and whether it is possible to identify people most vulnerable to serious infections early, and many questions remain unanswered, such as what interventions can help In reducing the severity of the disease, and what vaccines may prove effective.
The center recently announced an innovative treatment for patients (Covid-19) that seems to help the body fight the virus and thus reduce the severity of the infection.
The treatment includes extracting the stem cells from the patient's own blood and re-entering them into the lungs with a fine mist after its reactivation. The treatment has so far achieved a 100 percent success rate.
Staff at the center are currently receiving training in operating the new device, which they called "Lamborghini".
In another development announced today, the Abu Dhabi Stem Cell Center will begin offering highly sensitive tests to measure the "minimum remaining disease" for cancer patients, which is being conducted for the first time in the United Arab Emirates.
This very accurate test allows doctors to discover the remaining resistance cells that can lead to a new relapse in patients .. This test was not available in the UAE, where cancer patients had to travel abroad to conduct it, especially since it requires the use of a modern blood sample to obtain accurate results.
The availability of this test in the UAE represents an important step forward in the treatment of cancer, especially for adults and children with "myeloma" or multiple myeloma and leukemia.
It is noteworthy that the Abu Dhabi Stem Cell Center is a specialized health care center focused on regenerative medicine, researching stem cells and using them in treatment.